BF.B
57
7
VNO
59
3
VRTX
56
-4
MS
50
-8
BAC
39
-2
SWK
80
2
PNR
72
-2
D
55
-6
VRSN
50
-5
NUE
50
3
HES
59
3
QRVO
33
-3
CMCSA
52
6
FOX
39
2
INTU
60
-3
TRV
64
-3
EQT
44
2
EXC
50
-4
NRG
57
2
NEE
52
-2
BF.B
57
7
VNO
59
3
VRTX
56
-4
MS
50
-8
BAC
39
-2
SWK
80
2
PNR
72
-2
D
55
-6
VRSN
50
-5
NUE
50
3
HES
59
3
QRVO
33
-3
CMCSA
52
6
FOX
39
2
INTU
60
-3
TRV
64
-3
EQT
44
2
EXC
50
-4
NRG
57
2
NEE
52
-2
Financhill
Back

Crinetics Pharmaceuticals 10K Form

Sell
50

CRNX
Crinetics Pharmaceuticals

Last Price:
53.91
Seasonality Move:
3%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CRNX News And Ratings

See the #1 stock for the next 7 days that we like better than CRNX

CRNX Financial Statistics

Sales & Book Value

Annual Sales: $4.01M
Cash Flow: $-46.57M
Price / Cash Flow: 0
Annual Sales: $10.47
Price / Book: 5.08

Profitability

EPS (TTM): -3.78000
Net Income (TTM): $-258.54M
Gross Margin: --
Return on Equity: -42.43%
Return on Assets: -37.11%

Crinetics Pharmaceuticals Earnings Forecast

Key Crinetics Pharmaceuticals Financial Ratios

  • The Research & Development expenses have been 4,199.53% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of CRNX is -5,345.85% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 1 years.

Crinetics Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CRNX
CUSIP: 22663K
Website: crinetics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 16.09
Quick Ratio: 15.96

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CRNX Technical Analysis vs Fundamental Analysis

Sell
50
Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals a Buy or a Sell?